Company Filing History:
Years Active: 2014
Title: Emil Samara: Innovator in Endobronchial Infection Treatment
Introduction
Emil Samara is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of endobronchial infections. His innovative approach has the potential to improve patient outcomes and enhance therapeutic options.
Latest Patents
Emil Samara holds a patent for "Methods of treatment of endobronchial infections." This invention provides methods for treating an endobronchial infection in a patient by administering a dry powder aerosol composition containing from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a treatment period of 20 to 36 days. This patent highlights his commitment to advancing medical treatments.
Career Highlights
Samara is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.
Collaborations
Some of his notable coworkers include Peter Bruce Challoner and Carlos M Rodriguez. Their collaboration has likely fostered an environment of innovation and shared expertise, further enhancing the impact of their work.
Conclusion
Emil Samara's contributions to the treatment of endobronchial infections exemplify the importance of innovation in healthcare. His patent and work at Novartis AG reflect a dedication to improving patient care through scientific advancements.